1. Home
  2. OCFC vs RAPP Comparison

OCFC vs RAPP Comparison

Compare OCFC & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OceanFirst Financial Corp.

OCFC

OceanFirst Financial Corp.

HOLD

Current Price

$19.22

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$28.82

Market Cap

1.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
OCFC
RAPP
Founded
1902
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
1996
2024

Fundamental Metrics

Financial Performance
Metric
OCFC
RAPP
Price
$19.22
$28.82
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
$21.33
$47.00
AVG Volume (30 Days)
778.7K
331.7K
Earning Date
01-22-2026
03-10-2026
Dividend Yield
4.09%
N/A
EPS Growth
N/A
N/A
EPS
1.17
N/A
Revenue
$388,753,000.00
N/A
Revenue This Year
$46.71
N/A
Revenue Next Year
$21.25
N/A
P/E Ratio
$16.74
N/A
Revenue Growth
3.60
N/A
52 Week Low
$14.29
$6.43
52 Week High
$20.61
$42.27

Technical Indicators

Market Signals
Indicator
OCFC
RAPP
Relative Strength Index (RSI) 55.51 56.49
Support Level $18.15 $25.78
Resistance Level $20.02 $27.60
Average True Range (ATR) 0.58 1.69
MACD 0.12 0.20
Stochastic Oscillator 60.90 97.62

Price Performance

Historical Comparison
OCFC
RAPP

About OCFC OceanFirst Financial Corp.

OceanFirst Financial Corp is engaged in the banking sector of the United States. It conducts the business of attracting retail and business deposits and investing them in loans, consisting of single-family, owner-occupied residential mortgage loans, and commercial real estate loans. The company's sole segment deals with the delivery of loan and deposit products to customers. The bank's revenues are derived principally from interest on its loans, and to a lesser extent, interest on its investment and mortgage-backed securities. The rest of its income is dependent on bank card services and wealth management products and services.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: